Laszlo Takacs is the CEO/CSO of Biosystems International. He funded Biosystems International in France and Hungary. Prior to Biosystems, he worked at Pfizer and Amgen in various management roles in biotech and drug R&D and translational medicine. Before his industrial experience, he was the Head of the Special Unit of NIAAA, National Institute of Health. He continues academic activities by teaching Medical Genome Biology at the University of Debrecen in Hungary. He holds an MD degree in General Medicine and a PhD in Molecular Sciences from Semmelweis University and the Academy of Sciences in Hungary. Laszlo Takacs is the CEO/CSO of Biosystems International. He funded Biosystems International in France and Hungary. Prior to Biosystems, he worked at Pfizer and Amgen in various management roles in biotech and drug R&D and translational medicine. Before his industrial experience, he was the Head of the Special Unit of NIAAA, National Institute of Health. He continues academic activities by teaching Medical Genome Biology at the University of Debrecen in Hungary. He holds an MD degree in General Medicine and a PhD in Molecular Sciences from Semmelweis University and the Academy of Sciences in Hungary.

Projection of the impact of biomarker technology on medical diagnostics: Special focus on proteins